Clinical Trials Browser

Phase 1/2 × Carcinoma, Non-Small-Cell Lung × aumolertinib × Clear all

NCT02981108 2023-01-23

A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC

Phase 1/2 Unknown

364 enrolled 29 charts

Carcinoma, Non-Small-Cell Lung